Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study on the Relation of Nutrition and Immunotherapy of Cancer Patients

NCT06500234 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT06500234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06500234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study on the Relation of Nutrition and Immunotherapy of Cancer Patients
Lead sponsor
Qingdao Central Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
June 1, 2024
Completion date
May 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, immunotherapy, nutrition disorders, survival, prosthesis